

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 7.96479453 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.24236031 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.24236031 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.08425843 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.08425843 |
| 6 | hemidesmosome assembly (GO:0031581) | 5.90741832 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.32583615 |
| 8 | cysteine metabolic process (GO:0006534) | 5.23221714 |
| 9 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.20223837 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 5.10675124 |
| 11 | intestinal cholesterol absorption (GO:0030299) | 5.02930667 |
| 12 | regulation of water loss via skin (GO:0033561) | 4.99515614 |
| 13 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.91368057 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.73241320 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 4.56880392 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.56880392 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.56880392 |
| 18 | homocysteine metabolic process (GO:0050667) | 4.51404009 |
| 19 | glyoxylate metabolic process (GO:0046487) | 4.50426535 |
| 20 | tryptophan metabolic process (GO:0006568) | 4.47979240 |
| 21 | establishment of skin barrier (GO:0061436) | 4.45877060 |
| 22 | kynurenine metabolic process (GO:0070189) | 4.44150659 |
| 23 | urea cycle (GO:0000050) | 4.43048202 |
| 24 | urea metabolic process (GO:0019627) | 4.43048202 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 4.42053217 |
| 26 | bile acid biosynthetic process (GO:0006699) | 4.35382574 |
| 27 | lysine metabolic process (GO:0006553) | 4.32509501 |
| 28 | lysine catabolic process (GO:0006554) | 4.32509501 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.27334774 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.23741863 |
| 31 | multicellular organismal water homeostasis (GO:0050891) | 4.21734243 |
| 32 | regulation of cholesterol homeostasis (GO:2000188) | 4.19086121 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 4.11716000 |
| 34 | protein carboxylation (GO:0018214) | 4.10355271 |
| 35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.10355271 |
| 36 | intestinal absorption (GO:0050892) | 4.04838797 |
| 37 | amino-acid betaine metabolic process (GO:0006577) | 4.02256906 |
| 38 | activation of Rac GTPase activity (GO:0032863) | 4.01323345 |
| 39 | bile acid metabolic process (GO:0008206) | 4.01002620 |
| 40 | serine family amino acid catabolic process (GO:0009071) | 4.00635316 |
| 41 | drug transmembrane transport (GO:0006855) | 3.97604570 |
| 42 | epithelial cell-cell adhesion (GO:0090136) | 3.96587246 |
| 43 | phospholipid efflux (GO:0033700) | 3.91361916 |
| 44 | aromatic amino acid family metabolic process (GO:0009072) | 3.90710324 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 3.88039856 |
| 46 | negative regulation of sterol transport (GO:0032372) | 3.87200323 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 3.87200323 |
| 48 | reverse cholesterol transport (GO:0043691) | 3.84523784 |
| 49 | bile acid and bile salt transport (GO:0015721) | 3.84441468 |
| 50 | drug catabolic process (GO:0042737) | 3.83053061 |
| 51 | triglyceride homeostasis (GO:0070328) | 3.80352677 |
| 52 | acylglycerol homeostasis (GO:0055090) | 3.80352677 |
| 53 | complement activation, alternative pathway (GO:0006957) | 3.76250721 |
| 54 | negative regulation of fibrinolysis (GO:0051918) | 3.75343066 |
| 55 | regulation of protein activation cascade (GO:2000257) | 3.74396002 |
| 56 | GDP-mannose metabolic process (GO:0019673) | 3.71831035 |
| 57 | regulation of cholesterol esterification (GO:0010872) | 3.70936318 |
| 58 | regulation of fibrinolysis (GO:0051917) | 3.69208076 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 3.68087380 |
| 60 | tyrosine metabolic process (GO:0006570) | 3.67372185 |
| 61 | valine metabolic process (GO:0006573) | 3.66145702 |
| 62 | alpha-amino acid catabolic process (GO:1901606) | 3.64575511 |
| 63 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.64346768 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 3.64312591 |
| 65 | regulation of bile acid biosynthetic process (GO:0070857) | 3.59711306 |
| 66 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.59151173 |
| 67 | regulation of complement activation (GO:0030449) | 3.52316461 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 3.51821054 |
| 69 | COPI coating of Golgi vesicle (GO:0048205) | 3.50287351 |
| 70 | Golgi transport vesicle coating (GO:0048200) | 3.50287351 |
| 71 | plasma lipoprotein particle assembly (GO:0034377) | 3.48672220 |
| 72 | protein-lipid complex remodeling (GO:0034368) | 3.48092086 |
| 73 | macromolecular complex remodeling (GO:0034367) | 3.48092086 |
| 74 | plasma lipoprotein particle remodeling (GO:0034369) | 3.48092086 |
| 75 | fatty acid oxidation (GO:0019395) | 3.46287009 |
| 76 | fatty acid beta-oxidation (GO:0006635) | 3.46277070 |
| 77 | response to nitrosative stress (GO:0051409) | 3.44962077 |
| 78 | flavonoid metabolic process (GO:0009812) | 3.44798340 |
| 79 | urate metabolic process (GO:0046415) | 3.44418555 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 3.43015833 |
| 81 | water homeostasis (GO:0030104) | 3.42592901 |
| 82 | short-chain fatty acid metabolic process (GO:0046459) | 3.41631069 |
| 83 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.40320192 |
| 84 | ethanol oxidation (GO:0006069) | 3.39850865 |
| 85 | cholesterol efflux (GO:0033344) | 3.38899188 |
| 86 | cellular glucuronidation (GO:0052695) | 3.38373948 |
| 87 | lipid oxidation (GO:0034440) | 3.37059350 |
| 88 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.36444879 |
| 89 | 4-hydroxyproline metabolic process (GO:0019471) | 3.36284190 |
| 90 | serine family amino acid metabolic process (GO:0009069) | 3.35555805 |
| 91 | cholesterol homeostasis (GO:0042632) | 3.33285622 |
| 92 | indolalkylamine metabolic process (GO:0006586) | 3.32902570 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.32490154 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.32490154 |
| 95 | proline biosynthetic process (GO:0006561) | 3.30691669 |
| 96 | drug metabolic process (GO:0017144) | 3.29328660 |
| 97 | sterol homeostasis (GO:0055092) | 3.28639743 |
| 98 | cell-substrate junction assembly (GO:0007044) | 3.28393312 |
| 99 | drug transport (GO:0015893) | 3.27996336 |
| 100 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.26963121 |
| 101 | glutamate metabolic process (GO:0006536) | 3.26655680 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.26405202 |
| 103 | angiotensin maturation (GO:0002003) | 3.24991774 |
| 104 | fatty acid catabolic process (GO:0009062) | 3.24708979 |
| 105 | carboxylic acid catabolic process (GO:0046395) | 3.22780861 |
| 106 | organic acid catabolic process (GO:0016054) | 3.22780861 |
| 107 | lipoprotein metabolic process (GO:0042157) | 3.22312755 |
| 108 | semaphorin-plexin signaling pathway (GO:0071526) | 3.22206426 |
| 109 | plasma lipoprotein particle clearance (GO:0034381) | 3.20582196 |
| 110 | monocarboxylic acid catabolic process (GO:0072329) | 3.20460820 |
| 111 | xenobiotic catabolic process (GO:0042178) | 3.15415128 |
| 112 | regulation of viral release from host cell (GO:1902186) | 3.15178635 |
| 113 | glycine metabolic process (GO:0006544) | 3.14002915 |
| 114 | COPII vesicle coating (GO:0048208) | 3.13577270 |
| 115 | protein-lipid complex assembly (GO:0065005) | 3.13114567 |
| 116 | coenzyme catabolic process (GO:0009109) | 3.12066559 |
| 117 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.11983164 |
| 118 | carnitine metabolic process (GO:0009437) | 3.11812870 |
| 119 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.11593088 |
| 120 | ketone body metabolic process (GO:1902224) | 3.11484493 |
| 121 | mannose metabolic process (GO:0006013) | 3.10871100 |
| 122 | exogenous drug catabolic process (GO:0042738) | 3.10755926 |
| 123 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.07938322 |
| 124 | positive regulation of epidermis development (GO:0045684) | 3.06784406 |
| 125 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.06718347 |
| 126 | glucose 6-phosphate metabolic process (GO:0051156) | 3.06477019 |
| 127 | surfactant homeostasis (GO:0043129) | 3.06156325 |
| 128 | negative regulation of viral release from host cell (GO:1902187) | 3.01346503 |
| 129 | NADH metabolic process (GO:0006734) | 3.01190042 |
| 130 | glutathione biosynthetic process (GO:0006750) | 3.00405677 |
| 131 | apoptotic process involved in morphogenesis (GO:0060561) | 3.00130544 |
| 132 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.93946745 |
| 133 | intestinal epithelial cell development (GO:0060576) | 2.91574169 |
| 134 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.89923728 |
| 135 | atrioventricular valve morphogenesis (GO:0003181) | 2.89591243 |
| 136 | negative regulation of cell size (GO:0045792) | 2.89265771 |
| 137 | regulation of cholesterol metabolic process (GO:0090181) | 2.85455615 |
| 138 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.85347976 |
| 139 | amyloid precursor protein metabolic process (GO:0042982) | 2.84149262 |
| 140 | cell-cell junction maintenance (GO:0045217) | 2.78839160 |
| 141 | amyloid precursor protein catabolic process (GO:0042987) | 2.77907261 |
| 142 | endothelial cell chemotaxis (GO:0035767) | 2.77487191 |
| 143 | peptide catabolic process (GO:0043171) | 2.77008261 |
| 144 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.75089403 |
| 145 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.73817242 |
| 146 | maternal placenta development (GO:0001893) | 2.73681945 |
| 147 | positive regulation of histone deacetylation (GO:0031065) | 2.72938292 |
| 148 | regulation of extracellular matrix disassembly (GO:0010715) | 2.70618787 |
| 149 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.69265026 |
| 150 | regulation of keratinocyte differentiation (GO:0045616) | 2.68363281 |
| 151 | protein localization to endosome (GO:0036010) | 2.68270334 |
| 152 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.65668245 |
| 153 | regulation of ruffle assembly (GO:1900027) | 2.64254880 |
| 154 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.63233899 |
| 155 | protein retention in ER lumen (GO:0006621) | 2.63218152 |
| 156 | cell-substrate adherens junction assembly (GO:0007045) | 2.62650915 |
| 157 | focal adhesion assembly (GO:0048041) | 2.62650915 |
| 158 | fructose metabolic process (GO:0006000) | 2.62006082 |
| 159 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.61404756 |
| 160 | regulation of integrin activation (GO:0033623) | 2.61124625 |
| 161 | adherens junction assembly (GO:0034333) | 2.60543788 |
| 162 | NIK/NF-kappaB signaling (GO:0038061) | 2.59826516 |
| 163 | proline metabolic process (GO:0006560) | 2.56248938 |
| 164 | keratinocyte proliferation (GO:0043616) | 2.55803432 |
| 165 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.52761901 |
| 166 | response to food (GO:0032094) | 2.51228035 |
| 167 | regulation of vitamin metabolic process (GO:0030656) | 2.49818856 |
| 168 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.49340369 |
| 169 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.48998050 |
| 170 | sphingomyelin metabolic process (GO:0006684) | 2.47624879 |
| 171 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.46495464 |
| 172 | tight junction assembly (GO:0070830) | 2.46091288 |
| 173 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.44378936 |
| 174 | cellular response to virus (GO:0098586) | 2.44224075 |
| 175 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.44118442 |
| 176 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.44113961 |
| 177 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.44054056 |
| 178 | positive regulation of pseudopodium assembly (GO:0031274) | 2.43666817 |
| 179 | embryonic process involved in female pregnancy (GO:0060136) | 2.42221987 |
| 180 | glucose catabolic process (GO:0006007) | 2.41849899 |
| 181 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.41076299 |
| 182 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.39898630 |
| 183 | ear development (GO:0043583) | 2.38547730 |
| 184 | negative regulation of fatty acid transport (GO:2000192) | 2.38246403 |
| 185 | activation of MAPKKK activity (GO:0000185) | 2.37870971 |
| 186 | citrulline biosynthetic process (GO:0019240) | 2.37194830 |
| 187 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.37143220 |
| 188 | citrulline metabolic process (GO:0000052) | 2.35450367 |
| 189 | epoxygenase P450 pathway (GO:0019373) | 2.35078977 |
| 190 | striated muscle atrophy (GO:0014891) | 2.34996407 |
| 191 | trophectodermal cell differentiation (GO:0001829) | 2.34058294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.71953501 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52798472 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.88464104 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.21802574 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.96834543 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.10066372 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.09834157 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.97724522 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.93837357 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.19732356 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.04020991 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.88756044 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.39216592 |
| 14 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.35300130 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23033827 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.22662725 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.16817387 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.13870829 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.09022817 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97902047 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94495212 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91599430 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.90343922 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.89712560 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.86515435 |
| 26 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.84694981 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79304407 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 1.77728010 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.69679423 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.69174680 |
| 31 | * TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.65049631 |
| 32 | P68_20966046_ChIP-Seq_HELA_Human | 1.64706394 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63159609 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.58673254 |
| 35 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.55523280 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54947143 |
| 37 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54442798 |
| 38 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.54295808 |
| 39 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.53488858 |
| 40 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.52608277 |
| 41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.52324849 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51991603 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51496274 |
| 44 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.50159119 |
| 45 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.45075945 |
| 46 | KDM2B_26808549_Chip-Seq_K562_Human | 1.43754858 |
| 47 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.43712102 |
| 48 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38068945 |
| 49 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36974700 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34471242 |
| 51 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30769563 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29589668 |
| 53 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29012932 |
| 54 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.28658856 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28292067 |
| 56 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27812848 |
| 57 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.26737648 |
| 58 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23096296 |
| 59 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.22491015 |
| 60 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22015304 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21020424 |
| 62 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.19548215 |
| 63 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.18765740 |
| 64 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18449832 |
| 65 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18153943 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16914268 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16063109 |
| 68 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14964838 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13756022 |
| 70 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13581299 |
| 71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13308930 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12224975 |
| 73 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12020437 |
| 74 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11082752 |
| 75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10422314 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10115159 |
| 77 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07201325 |
| 78 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06868295 |
| 79 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.06816500 |
| 80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06746799 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05140033 |
| 82 | MAF_26560356_Chip-Seq_TH1_Human | 1.04165368 |
| 83 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.03233645 |
| 84 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03206916 |
| 85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02641494 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02421372 |
| 87 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02350732 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02159074 |
| 89 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00987201 |
| 90 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00919635 |
| 91 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00891598 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00567896 |
| 93 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99871729 |
| 94 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99828730 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99462142 |
| 96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99376078 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98785208 |
| 98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95663080 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95025652 |
| 100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94034214 |
| 101 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.92073898 |
| 102 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91656893 |
| 103 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91120815 |
| 104 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.90299693 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90081420 |
| 106 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88949721 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87936492 |
| 108 | ATF3_27146783_Chip-Seq_COLON_Human | 0.87932622 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87665821 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87262507 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.85670891 |
| 112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85656836 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84633687 |
| 114 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83259896 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82850223 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82106128 |
| 117 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81180189 |
| 118 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81156409 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80272386 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79699679 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78575818 |
| 122 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77652611 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.76218967 |
| 124 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76199088 |
| 125 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.75458340 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73737255 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72189502 |
| 128 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.71905625 |
| 129 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.71881950 |
| 130 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.71881950 |
| 131 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.71254978 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.70664219 |
| 133 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70000395 |
| 134 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.69325092 |
| 135 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.64854236 |
| 136 | AR_20517297_ChIP-Seq_VCAP_Human | 0.64766396 |
| 137 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.64574370 |
| 138 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63765313 |
| 139 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.62765445 |
| 140 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.62674856 |
| 141 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.61966890 |
| 142 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.61045183 |
| 143 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.61045183 |
| 144 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.60605383 |
| 145 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.60554361 |
| 146 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.59717556 |
| 147 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58660355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.41978223 |
| 2 | MP0005360_urolithiasis | 6.06568343 |
| 3 | MP0005365_abnormal_bile_salt | 5.24774743 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.06937152 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.09010252 |
| 6 | MP0001666_abnormal_nutrient_absorption | 3.59740008 |
| 7 | MP0003252_abnormal_bile_duct | 3.23340445 |
| 8 | MP0005083_abnormal_biliary_tract | 3.07225651 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.96133174 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.83671761 |
| 11 | MP0003195_calcinosis | 2.58214067 |
| 12 | MP0009840_abnormal_foam_cell | 2.40905092 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.38284743 |
| 14 | MP0005332_abnormal_amino_acid | 2.26255539 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.24912791 |
| 16 | MP0005409_darkened_coat_color | 2.24778911 |
| 17 | MP0004264_abnormal_extraembryonic_tissu | 2.23877610 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 2.18159197 |
| 19 | MP0002254_reproductive_system_inflammat | 2.07499497 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.98515678 |
| 21 | MP0005076_abnormal_cell_differentiation | 1.95969371 |
| 22 | MP0009643_abnormal_urine_homeostasis | 1.91988130 |
| 23 | MP0003868_abnormal_feces_composition | 1.87838399 |
| 24 | MP0004858_abnormal_nervous_system | 1.87173443 |
| 25 | MP0000609_abnormal_liver_physiology | 1.83688274 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.78224046 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.77764845 |
| 28 | MP0005220_abnormal_exocrine_pancreas | 1.77748431 |
| 29 | MP0008260_abnormal_autophagy | 1.69440500 |
| 30 | MP0004381_abnormal_hair_follicle | 1.69062467 |
| 31 | MP0004043_abnormal_pH_regulation | 1.61724520 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.60071409 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.45240491 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.42448200 |
| 35 | MP0000537_abnormal_urethra_morphology | 1.42212623 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 1.38417033 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.31037044 |
| 38 | MP0010771_integument_phenotype | 1.28216387 |
| 39 | MP0001764_abnormal_homeostasis | 1.26551195 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.24810945 |
| 41 | MP0000858_altered_metastatic_potential | 1.24806881 |
| 42 | MP0009931_abnormal_skin_appearance | 1.24799976 |
| 43 | MP0001756_abnormal_urination | 1.23779520 |
| 44 | MP0000490_abnormal_crypts_of | 1.21960507 |
| 45 | MP0002796_impaired_skin_barrier | 1.21495009 |
| 46 | MP0003436_decreased_susceptibility_to | 1.19131488 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.18753583 |
| 48 | MP0001944_abnormal_pancreas_morphology | 1.16842311 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.16801652 |
| 50 | MP0005023_abnormal_wound_healing | 1.14740877 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 1.13443681 |
| 52 | MP0003303_peritoneal_inflammation | 1.12352036 |
| 53 | MP0001765_abnormal_ion_homeostasis | 1.09047516 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.08304801 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06728569 |
| 56 | MP0003186_abnormal_redox_activity | 1.05756045 |
| 57 | MP0000627_abnormal_mammary_gland | 1.05190849 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 1.02906159 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.01984567 |
| 60 | MP0002693_abnormal_pancreas_physiology | 1.01152261 |
| 61 | MP0003941_abnormal_skin_development | 1.00243561 |
| 62 | MP0000598_abnormal_liver_morphology | 0.98384099 |
| 63 | MP0002098_abnormal_vibrissa_morphology | 0.97928633 |
| 64 | MP0000462_abnormal_digestive_system | 0.95404988 |
| 65 | MP0002136_abnormal_kidney_physiology | 0.93728706 |
| 66 | MP0000762_abnormal_tongue_morphology | 0.93205241 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 0.91965161 |
| 68 | MP0005375_adipose_tissue_phenotype | 0.91798762 |
| 69 | MP0000678_abnormal_parathyroid_gland | 0.88840899 |
| 70 | MP0002249_abnormal_larynx_morphology | 0.86734999 |
| 71 | MP0010678_abnormal_skin_adnexa | 0.85957861 |
| 72 | MP0002928_abnormal_bile_duct | 0.84596901 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 0.84376436 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.84058914 |
| 75 | MP0000003_abnormal_adipose_tissue | 0.83468971 |
| 76 | MP0005310_abnormal_salivary_gland | 0.83023554 |
| 77 | MP0002060_abnormal_skin_morphology | 0.82794168 |
| 78 | MP0003283_abnormal_digestive_organ | 0.82526716 |
| 79 | MP0000367_abnormal_coat/_hair | 0.81812192 |
| 80 | MP0000579_abnormal_nail_morphology | 0.81680340 |
| 81 | MP0009642_abnormal_blood_homeostasis | 0.81318829 |
| 82 | MP0005408_hypopigmentation | 0.80904274 |
| 83 | MP0002089_abnormal_postnatal_growth/wei | 0.80545671 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.78492016 |
| 85 | MP0005275_abnormal_skin_tensile | 0.77925163 |
| 86 | MP0003878_abnormal_ear_physiology | 0.76198111 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.76198111 |
| 88 | MP0009697_abnormal_copulation | 0.75214222 |
| 89 | MP0004947_skin_inflammation | 0.75078334 |
| 90 | MP0001873_stomach_inflammation | 0.75069606 |
| 91 | MP0010155_abnormal_intestine_physiology | 0.74563869 |
| 92 | MP0005647_abnormal_sex_gland | 0.73505766 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.72321221 |
| 94 | MP0009764_decreased_sensitivity_to | 0.72126329 |
| 95 | MP0006054_spinal_hemorrhage | 0.70540958 |
| 96 | MP0000538_abnormal_urinary_bladder | 0.70379190 |
| 97 | MP0005025_abnormal_response_to | 0.70175815 |
| 98 | MP0008469_abnormal_protein_level | 0.69714280 |
| 99 | MP0000470_abnormal_stomach_morphology | 0.69372910 |
| 100 | MP0001849_ear_inflammation | 0.69260484 |
| 101 | MP0005334_abnormal_fat_pad | 0.69125402 |
| 102 | MP0010368_abnormal_lymphatic_system | 0.69029711 |
| 103 | MP0000427_abnormal_hair_cycle | 0.68079519 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.68012040 |
| 105 | MP0000383_abnormal_hair_follicle | 0.67766608 |
| 106 | MP0000613_abnormal_salivary_gland | 0.67677831 |
| 107 | MP0004510_myositis | 0.67419548 |
| 108 | MP0003866_abnormal_defecation | 0.66856748 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.65509731 |
| 110 | MP0002909_abnormal_adrenal_gland | 0.65439619 |
| 111 | MP0005451_abnormal_body_composition | 0.65405341 |
| 112 | MP0001663_abnormal_digestive_system | 0.65344501 |
| 113 | MP0009763_increased_sensitivity_to | 0.64279829 |
| 114 | MP0003879_abnormal_hair_cell | 0.63855737 |
| 115 | MP0005501_abnormal_skin_physiology | 0.63476805 |
| 116 | MP0005257_abnormal_intraocular_pressure | 0.62619091 |
| 117 | MP0005670_abnormal_white_adipose | 0.61560328 |
| 118 | MP0005166_decreased_susceptibility_to | 0.61482991 |
| 119 | MP0003953_abnormal_hormone_level | 0.61247190 |
| 120 | MP0003091_abnormal_cell_migration | 0.60296734 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.59934803 |
| 122 | MP0005448_abnormal_energy_balance | 0.59339756 |
| 123 | MP0005058_abnormal_lysosome_morphology | 0.58672125 |
| 124 | MP0001845_abnormal_inflammatory_respons | 0.58415495 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.58405602 |
| 126 | MP0003123_paternal_imprinting | 0.57637297 |
| 127 | MP0000566_synostosis | 0.56935684 |
| 128 | MP0001881_abnormal_mammary_gland | 0.56353045 |
| 129 | MP0009384_cardiac_valve_regurgitation | 0.54879519 |
| 130 | MP0001533_abnormal_skeleton_physiology | 0.53631932 |
| 131 | MP0001191_abnormal_skin_condition | 0.53254890 |
| 132 | MP0002148_abnormal_hypersensitivity_rea | 0.53198975 |
| 133 | MP0005381_digestive/alimentary_phenotyp | 0.52561360 |
| 134 | MP0004147_increased_porphyrin_level | 0.52518431 |
| 135 | MP0002971_abnormal_brown_adipose | 0.52276122 |
| 136 | MP0000477_abnormal_intestine_morphology | 0.51211630 |
| 137 | MP0000467_abnormal_esophagus_morphology | 0.50970803 |
| 138 | MP0002166_altered_tumor_susceptibility | 0.50882327 |
| 139 | MP0000377_abnormal_hair_follicle | 0.50819365 |
| 140 | MP0003566_abnormal_cell_adhesion | 0.49447203 |
| 141 | MP0001664_abnormal_digestion | 0.48161361 |
| 142 | MP0006036_abnormal_mitochondrial_physio | 0.48052780 |
| 143 | MP0005666_abnormal_adipose_tissue | 0.47705738 |
| 144 | MP0002896_abnormal_bone_mineralization | 0.47637664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.10163813 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.60867843 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.23802577 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.80098371 |
| 5 | Hypoglycemic coma (HP:0001325) | 4.79277911 |
| 6 | Xanthomatosis (HP:0000991) | 4.78933265 |
| 7 | Pili torti (HP:0003777) | 4.71926706 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.61018363 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.15752046 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.07446413 |
| 11 | Gout (HP:0001997) | 4.06744405 |
| 12 | Ketosis (HP:0001946) | 4.00130036 |
| 13 | Thin bony cortex (HP:0002753) | 3.97417279 |
| 14 | Abnormal hair laboratory examination (HP:0003328) | 3.90438289 |
| 15 | Hypoglycemic seizures (HP:0002173) | 3.81143195 |
| 16 | Fat malabsorption (HP:0002630) | 3.77612590 |
| 17 | Ketoacidosis (HP:0001993) | 3.73360307 |
| 18 | Hyperglycinuria (HP:0003108) | 3.71365127 |
| 19 | Abnormality of nail color (HP:0100643) | 3.59298982 |
| 20 | Hyperammonemia (HP:0001987) | 3.57192586 |
| 21 | Flat acetabular roof (HP:0003180) | 3.56699375 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.53954214 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.53518514 |
| 24 | Abnormality of purine metabolism (HP:0004352) | 3.53220016 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.52875692 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.49134742 |
| 27 | Hypolipoproteinemia (HP:0010981) | 3.48495542 |
| 28 | Plantar hyperkeratosis (HP:0007556) | 3.46689097 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.42622140 |
| 30 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.40695863 |
| 31 | Complement deficiency (HP:0004431) | 3.37012394 |
| 32 | Fragile nails (HP:0001808) | 3.29237267 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.29125824 |
| 34 | Epidermoid cyst (HP:0200040) | 3.21520659 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.18454245 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 3.18454245 |
| 37 | Symptomatic seizures (HP:0011145) | 3.15916638 |
| 38 | Broad face (HP:0000283) | 3.14725080 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13470566 |
| 40 | Hyperglycinemia (HP:0002154) | 3.11872144 |
| 41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.11087935 |
| 42 | Alopecia of scalp (HP:0002293) | 3.06969773 |
| 43 | Late onset (HP:0003584) | 3.02149386 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 2.98675526 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.93116003 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.92810025 |
| 47 | Hyperbilirubinemia (HP:0002904) | 2.92618596 |
| 48 | Joint hemorrhage (HP:0005261) | 2.88886800 |
| 49 | Abnormality of methionine metabolism (HP:0010901) | 2.88202657 |
| 50 | Thick nail (HP:0001805) | 2.82156035 |
| 51 | Generalized aminoaciduria (HP:0002909) | 2.79534917 |
| 52 | Right ventricular cardiomyopathy (HP:0011663) | 2.75134212 |
| 53 | Hyperglycemia (HP:0003074) | 2.74840777 |
| 54 | Steatorrhea (HP:0002570) | 2.69810735 |
| 55 | Atrophic scars (HP:0001075) | 2.69733674 |
| 56 | Nail dystrophy (HP:0008404) | 2.68504452 |
| 57 | Hyperactive renin-angiotensin system (HP:0000841) | 2.68353287 |
| 58 | Malnutrition (HP:0004395) | 2.66749547 |
| 59 | Palmoplantar hyperkeratosis (HP:0000972) | 2.66016651 |
| 60 | J-shaped sella turcica (HP:0002680) | 2.64246546 |
| 61 | Hyperuricemia (HP:0002149) | 2.60213024 |
| 62 | Increased purine levels (HP:0004368) | 2.60213024 |
| 63 | Abnormal blistering of the skin (HP:0008066) | 2.59859075 |
| 64 | Onycholysis (HP:0001806) | 2.58262586 |
| 65 | Metabolic acidosis (HP:0001942) | 2.56340278 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.54694479 |
| 67 | Distal lower limb muscle weakness (HP:0009053) | 2.54651958 |
| 68 | Esophageal varix (HP:0002040) | 2.52799332 |
| 69 | Hyperparathyroidism (HP:0000843) | 2.51086578 |
| 70 | Hypercholesterolemia (HP:0003124) | 2.50321418 |
| 71 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.50283808 |
| 72 | Cervical subluxation (HP:0003308) | 2.50069299 |
| 73 | Acanthocytosis (HP:0001927) | 2.49604198 |
| 74 | Hydroxyprolinuria (HP:0003080) | 2.48611234 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.48611234 |
| 76 | Vascular calcification (HP:0004934) | 2.43395842 |
| 77 | Hypoplasia of dental enamel (HP:0006297) | 2.40212232 |
| 78 | Ridged nail (HP:0001807) | 2.39320494 |
| 79 | Abnormality of complement system (HP:0005339) | 2.39130250 |
| 80 | Dicarboxylic aciduria (HP:0003215) | 2.38218956 |
| 81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.38218956 |
| 82 | Amelogenesis imperfecta (HP:0000705) | 2.38197465 |
| 83 | Distal lower limb amyotrophy (HP:0008944) | 2.36267873 |
| 84 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.35467675 |
| 85 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.35467675 |
| 86 | Palmar hyperkeratosis (HP:0010765) | 2.34799575 |
| 87 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.33971667 |
| 88 | Curly hair (HP:0002212) | 2.33223595 |
| 89 | Advanced eruption of teeth (HP:0006288) | 2.32547537 |
| 90 | Distal upper limb amyotrophy (HP:0007149) | 2.32453633 |
| 91 | Upper limb amyotrophy (HP:0009129) | 2.32453633 |
| 92 | Abdominal distention (HP:0003270) | 2.31678900 |
| 93 | Pancreatitis (HP:0001733) | 2.31252184 |
| 94 | Myocardial infarction (HP:0001658) | 2.30876940 |
| 95 | Alkalosis (HP:0001948) | 2.28316690 |
| 96 | Stridor (HP:0010307) | 2.27360172 |
| 97 | Axonal loss (HP:0003447) | 2.26337276 |
| 98 | Woolly hair (HP:0002224) | 2.26256452 |
| 99 | Pterygium (HP:0001059) | 2.25696981 |
| 100 | Hyperacusis (HP:0010780) | 2.18808192 |
| 101 | Delayed CNS myelination (HP:0002188) | 2.18634446 |
| 102 | Enlarged kidneys (HP:0000105) | 2.17498648 |
| 103 | Eczematoid dermatitis (HP:0000976) | 2.16492096 |
| 104 | Lip pit (HP:0100267) | 2.15389254 |
| 105 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.15278700 |
| 106 | Ileus (HP:0002595) | 2.14902933 |
| 107 | Abnormality of chloride homeostasis (HP:0011422) | 2.14416081 |
| 108 | Interstitial pulmonary disease (HP:0006530) | 2.12013319 |
| 109 | Hypotrichosis (HP:0001006) | 2.11708446 |
| 110 | Fragile skin (HP:0001030) | 2.10928549 |
| 111 | Cardiovascular calcification (HP:0011915) | 2.10823894 |
| 112 | Potter facies (HP:0002009) | 2.09364126 |
| 113 | Facial shape deformation (HP:0011334) | 2.09364126 |
| 114 | Abnormal gallbladder morphology (HP:0012437) | 2.09270996 |
| 115 | Widely patent fontanelles and sutures (HP:0004492) | 2.07874541 |
| 116 | Diaphragmatic weakness (HP:0009113) | 2.07570351 |
| 117 | Focal segmental glomerulosclerosis (HP:0000097) | 2.07314313 |
| 118 | Obstructive sleep apnea (HP:0002870) | 2.07223365 |
| 119 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.06996072 |
| 120 | Irritability (HP:0000737) | 2.06946858 |
| 121 | Lethargy (HP:0001254) | 2.06689317 |
| 122 | Spontaneous abortion (HP:0005268) | 2.05465183 |
| 123 | Glycosuria (HP:0003076) | 2.04729317 |
| 124 | Abnormality of urine glucose concentration (HP:0011016) | 2.04729317 |
| 125 | Proximal tubulopathy (HP:0000114) | 2.03980268 |
| 126 | Dysostosis multiplex (HP:0000943) | 2.03625961 |
| 127 | Abnormality of the gastric mucosa (HP:0004295) | 2.02399067 |
| 128 | Increased IgE level (HP:0003212) | 2.00826225 |
| 129 | Germ cell neoplasia (HP:0100728) | 2.00126772 |
| 130 | Nasal polyposis (HP:0100582) | 1.99948822 |
| 131 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.99662077 |
| 132 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.97807422 |
| 133 | Insulin resistance (HP:0000855) | 1.97380159 |
| 134 | Skin nodule (HP:0200036) | 1.97329804 |
| 135 | Abnormality of the nasal mucosa (HP:0000433) | 1.96918395 |
| 136 | Protuberant abdomen (HP:0001538) | 1.95352860 |
| 137 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.92753410 |
| 138 | Spastic diplegia (HP:0001264) | 1.91971659 |
| 139 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.91730044 |
| 140 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.91730044 |
| 141 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.91730044 |
| 142 | Poikilocytosis (HP:0004447) | 1.91703233 |
| 143 | Hypophosphatemia (HP:0002148) | 1.90591288 |
| 144 | Nephrolithiasis (HP:0000787) | 1.90385580 |
| 145 | Mucopolysacchariduria (HP:0008155) | 1.90123870 |
| 146 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90123870 |
| 147 | Short nail (HP:0001799) | 1.90079399 |
| 148 | Menorrhagia (HP:0000132) | 1.89755835 |
| 149 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.89587965 |
| 150 | Natal tooth (HP:0000695) | 1.89407076 |
| 151 | Decreased circulating renin level (HP:0003351) | 1.88099062 |
| 152 | Easy fatigability (HP:0003388) | 1.87909949 |
| 153 | Acanthosis nigricans (HP:0000956) | 1.87840736 |
| 154 | Hemorrhage of the eye (HP:0011885) | 1.87740084 |
| 155 | Bone pain (HP:0002653) | 1.87162353 |
| 156 | Increased cerebral lipofuscin (HP:0011813) | 1.86924763 |
| 157 | Abnormality of serum amino acid levels (HP:0003112) | 1.86677919 |
| 158 | Cholelithiasis (HP:0001081) | 1.86571582 |
| 159 | Cheilitis (HP:0100825) | 1.86357978 |
| 160 | Glomerulosclerosis (HP:0000096) | 1.86342907 |
| 161 | Abnormality of the salivary glands (HP:0010286) | 1.85825795 |
| 162 | Abnormal biliary tract morphology (HP:0012440) | 1.85784659 |
| 163 | Brushfield spots (HP:0001088) | 1.85474778 |
| 164 | Loss of speech (HP:0002371) | 1.83788032 |
| 165 | Rickets (HP:0002748) | 1.83582991 |
| 166 | Gingivitis (HP:0000230) | 1.82934427 |
| 167 | Septate vagina (HP:0001153) | 1.82686377 |
| 168 | Colitis (HP:0002583) | 1.81458066 |
| 169 | Milia (HP:0001056) | 1.81358888 |
| 170 | Pustule (HP:0200039) | 1.80038197 |
| 171 | Flattened epiphyses (HP:0003071) | 1.79938707 |
| 172 | Dehydration (HP:0001944) | 1.79165426 |
| 173 | Spinal cord compression (HP:0002176) | 1.78782195 |
| 174 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78387296 |
| 175 | Increased connective tissue (HP:0009025) | 1.78149832 |
| 176 | Abnormality of renin-angiotensin system (HP:0000847) | 1.76979875 |
| 177 | Progressive sensorineural hearing impairment (HP:0000408) | 1.75635486 |
| 178 | Progressive hearing impairment (HP:0001730) | 1.74977618 |
| 179 | Micronodular cirrhosis (HP:0001413) | 1.74162235 |
| 180 | Ankyloglossia (HP:0010296) | 1.74008686 |
| 181 | Hyperphosphatemia (HP:0002905) | 1.73805210 |
| 182 | Villous atrophy (HP:0011473) | 1.73440295 |
| 183 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.73440295 |
| 184 | Systemic lupus erythematosus (HP:0002725) | 1.73274536 |
| 185 | Polygenic inheritance (HP:0010982) | 1.72963195 |
| 186 | Elevated alkaline phosphatase (HP:0003155) | 1.72879367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.05627632 |
| 2 | BCKDK | 3.96574559 |
| 3 | INSRR | 3.37439319 |
| 4 | FRK | 3.36604793 |
| 5 | TAOK3 | 3.02572614 |
| 6 | FGFR4 | 2.87857908 |
| 7 | SMG1 | 2.87416266 |
| 8 | SIK1 | 2.86573215 |
| 9 | MAPK15 | 2.85375197 |
| 10 | EPHA2 | 2.74627101 |
| 11 | MST1R | 2.37151605 |
| 12 | PTK6 | 2.20227805 |
| 13 | TRIB3 | 2.13872606 |
| 14 | FLT3 | 2.08302527 |
| 15 | NME2 | 2.05517664 |
| 16 | MAP3K3 | 2.00256570 |
| 17 | PIK3CG | 1.92930020 |
| 18 | PKN2 | 1.87887051 |
| 19 | MAP3K2 | 1.77258602 |
| 20 | ICK | 1.74081594 |
| 21 | WNK4 | 1.73186377 |
| 22 | LATS1 | 1.65971933 |
| 23 | MAP2K2 | 1.65840974 |
| 24 | TAOK1 | 1.51131433 |
| 25 | EPHB1 | 1.49619433 |
| 26 | TESK1 | 1.47798439 |
| 27 | PRPF4B | 1.47241372 |
| 28 | LMTK2 | 1.43450616 |
| 29 | PASK | 1.41056356 |
| 30 | PTK2 | 1.39158319 |
| 31 | TYK2 | 1.29073722 |
| 32 | WNK3 | 1.27696437 |
| 33 | MST4 | 1.27367497 |
| 34 | IRAK3 | 1.27079428 |
| 35 | EPHA3 | 1.27034509 |
| 36 | MET | 1.19458886 |
| 37 | RIPK1 | 1.16592295 |
| 38 | MAP3K6 | 1.12012581 |
| 39 | MAP2K3 | 1.10581604 |
| 40 | NUAK1 | 1.09206290 |
| 41 | FER | 1.02390937 |
| 42 | MAP3K10 | 0.99190742 |
| 43 | CDC42BPA | 0.98883445 |
| 44 | ZAP70 | 0.97612205 |
| 45 | PRKD2 | 0.96222784 |
| 46 | ERBB4 | 0.95785015 |
| 47 | HIPK2 | 0.94152783 |
| 48 | MAP3K1 | 0.93554531 |
| 49 | BMX | 0.91659721 |
| 50 | MUSK | 0.91511940 |
| 51 | LRRK2 | 0.90381169 |
| 52 | MAPK11 | 0.89854724 |
| 53 | IRAK4 | 0.89512818 |
| 54 | JAK3 | 0.89035434 |
| 55 | DYRK1B | 0.88973214 |
| 56 | JAK2 | 0.87398372 |
| 57 | NEK9 | 0.87318421 |
| 58 | NME1 | 0.86542145 |
| 59 | TESK2 | 0.86460178 |
| 60 | RPS6KB2 | 0.85050230 |
| 61 | EPHB2 | 0.84182763 |
| 62 | FGFR2 | 0.83513361 |
| 63 | RPS6KA2 | 0.82344927 |
| 64 | TGFBR1 | 0.81751565 |
| 65 | PIM2 | 0.81388412 |
| 66 | TNK2 | 0.80623481 |
| 67 | CDK6 | 0.79187308 |
| 68 | PRKG2 | 0.78046688 |
| 69 | MAP3K7 | 0.76580902 |
| 70 | PIK3CA | 0.74647875 |
| 71 | ERBB2 | 0.74143450 |
| 72 | CAMK1D | 0.73887265 |
| 73 | ARAF | 0.73573782 |
| 74 | NLK | 0.73042013 |
| 75 | MAP2K6 | 0.72695641 |
| 76 | MARK2 | 0.72601513 |
| 77 | TAOK2 | 0.72005646 |
| 78 | CDK12 | 0.70810085 |
| 79 | MAPKAPK3 | 0.70763170 |
| 80 | IRAK2 | 0.70634967 |
| 81 | MAP3K11 | 0.69370294 |
| 82 | PDGFRA | 0.69203064 |
| 83 | JAK1 | 0.68844364 |
| 84 | PRKAA2 | 0.68706560 |
| 85 | TGFBR2 | 0.68643995 |
| 86 | RPS6KA4 | 0.68530303 |
| 87 | MAP3K13 | 0.67935074 |
| 88 | SIK3 | 0.66081039 |
| 89 | MTOR | 0.64773269 |
| 90 | RIPK4 | 0.64414085 |
| 91 | FGFR3 | 0.64271928 |
| 92 | PRKD3 | 0.63575636 |
| 93 | CHUK | 0.62885908 |
| 94 | MAP2K1 | 0.62726725 |
| 95 | MAP4K1 | 0.59550643 |
| 96 | TBK1 | 0.59282842 |
| 97 | PDK3 | 0.58251429 |
| 98 | PDK4 | 0.58251429 |
| 99 | RPS6KL1 | 0.58107462 |
| 100 | RPS6KC1 | 0.58107462 |
| 101 | PRKAA1 | 0.57349269 |
| 102 | PRKCI | 0.57341384 |
| 103 | GRK6 | 0.57249650 |
| 104 | GSK3A | 0.56642785 |
| 105 | EEF2K | 0.55848771 |
| 106 | IKBKE | 0.55676623 |
| 107 | DDR2 | 0.53833817 |
| 108 | BTK | 0.51346962 |
| 109 | STK38 | 0.49000313 |
| 110 | STK24 | 0.48173712 |
| 111 | CSK | 0.46997502 |
| 112 | MATK | 0.46138629 |
| 113 | KSR2 | 0.45114416 |
| 114 | CSF1R | 0.44092220 |
| 115 | MAP3K8 | 0.43226683 |
| 116 | IKBKB | 0.43213025 |
| 117 | PDK2 | 0.42602427 |
| 118 | RPS6KA6 | 0.41673601 |
| 119 | NEK6 | 0.41033477 |
| 120 | MAPKAPK2 | 0.40709411 |
| 121 | KDR | 0.40464833 |
| 122 | PAK4 | 0.39771166 |
| 123 | DAPK2 | 0.39426720 |
| 124 | EIF2AK3 | 0.39138071 |
| 125 | IRAK1 | 0.38629165 |
| 126 | STK38L | 0.38021930 |
| 127 | AKT3 | 0.37768763 |
| 128 | ILK | 0.36793056 |
| 129 | GRK1 | 0.36319537 |
| 130 | TIE1 | 0.36050020 |
| 131 | SCYL2 | 0.35340046 |
| 132 | PDGFRB | 0.34568119 |
| 133 | STK10 | 0.34494533 |
| 134 | FGR | 0.33661977 |
| 135 | ITK | 0.33596757 |
| 136 | MAP3K14 | 0.33060642 |
| 137 | SGK3 | 0.32810433 |
| 138 | PDPK1 | 0.31571322 |
| 139 | RET | 0.30295699 |
| 140 | CAMK1G | 0.29084486 |
| 141 | LATS2 | 0.28684253 |
| 142 | CDK9 | 0.27109345 |
| 143 | CDK7 | 0.26493639 |
| 144 | PRKACG | 0.24679547 |
| 145 | PRKCZ | 0.24519135 |
| 146 | BRAF | 0.23662477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.47016379 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33431526 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.13961113 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69287022 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.63425418 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.57673808 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52431546 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49936453 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.31907064 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.31086547 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.31061760 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.22292077 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.14966911 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.10540405 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.08109994 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07967488 |
| 17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.01696721 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.97215108 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.92434596 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91209296 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.90382307 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.89261822 |
| 23 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.88387258 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86509640 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82812661 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81008129 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.79696488 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67881961 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65101473 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59002528 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55888140 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.55827588 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.53517550 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.52673689 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51750833 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45941498 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.44020818 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36583418 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.36473048 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.33029129 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29994761 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28221463 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.27967801 |
| 44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.23839744 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23491690 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23400108 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.22348185 |
| 48 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.20346064 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19435378 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16965013 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.13259152 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10920802 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08922250 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06547711 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05409476 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.03332353 |
| 57 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.02303577 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 1.01817322 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97370870 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96945671 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96281476 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94377493 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93632907 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.93445420 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91160385 |
| 66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.89547505 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89313416 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88730042 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87527887 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85016007 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83792304 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.82833073 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81360391 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.81104005 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78512699 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78274997 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.77550722 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76290757 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75596264 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74455378 |
| 81 | Protein export_Homo sapiens_hsa03060 | 0.73875105 |
| 82 | Influenza A_Homo sapiens_hsa05164 | 0.73597945 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.71525674 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71441568 |
| 85 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71099018 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70230326 |
| 87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69869697 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69227771 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68520582 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66777116 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.65031406 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64731284 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64586937 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.64243495 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63680018 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63674044 |
| 97 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.63440607 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.63362634 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61196462 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61051333 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60522451 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60466260 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59503020 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59309034 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58704350 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.58084974 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.57677829 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57222681 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56149905 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55519769 |
| 111 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53878609 |
| 112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53247343 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52500452 |
| 114 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51470025 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | 0.49678089 |
| 116 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.48832777 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48521519 |
| 118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48131798 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47919855 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45046760 |
| 121 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43258231 |
| 122 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41485099 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40568402 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34265543 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33858175 |
| 126 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32149798 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25941201 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.23923696 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23785488 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22251153 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | 0.21891335 |
| 132 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19469977 |
| 133 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.18742987 |
| 134 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.14698955 |
| 135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.12535201 |
| 136 | Lysosome_Homo sapiens_hsa04142 | 0.10781109 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.10175537 |
| 138 | Hepatitis C_Homo sapiens_hsa05160 | 0.09674683 |
| 139 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06296426 |
| 140 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.05233737 |
| 141 | Circadian rhythm_Homo sapiens_hsa04710 | 0.02407047 |
| 142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02242130 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0142739 |

